Federal lawmakers have released excerpts from thousands of documents detailing how two drugmakers hiked prices to squeeze more revenue from some life-saving medicines, a practice that has recently sparked public outrage.
mardi 2 février 2016
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire